Sarcopenia is a loss of muscle protein mass and loss of muscle function. It occurs with increasing age, being a major component
in the development of frailty. Current knowledge on its assessment, etiology, pathogenesis, consequences and future perspectives
are reported in the present review. On-going and future clinical trials on sarcopenia may radically change our preventive
and therapeutic approaches of mobility disability in older people.